West Pharmaceutical Services (WST) Long-Term Debt Issuances (2009 - 2024)

West Pharmaceutical Services (WST) has reported Long-Term Debt Issuances for 13 consecutive years, with $129.7 million the latest figure, recorded in Q3 2024.

• Quarterly Long-Term Debt Issuances rose 21516.67% year-over-year to $129.7 million in Q3 2024, while the trailing twelve-month figure through Dec 2025 was $129.7 million (down 21.25% YoY) and the FY2024 annual result came in at $164.7 million, changed N/A from the prior year.
• Long-Term Debt Issuances climbed to $129.7 million in Q3 2024 per WST's latest filing, from $34.4 million in the prior quarter.
• Over the last five years, Long-Term Debt Issuances for WST reached as high as $129.7 million in Q3 2024 and fell as low as -$43.7 million in Q4 2022.
• A 5-year average of $9.3 million and a median of $600000.0 in 2020 frame the typical range for Long-Term Debt Issuances.
• Annual changes were most pronounced in 2022 — Long-Term Debt Issuances slumped 4072.73% — and 2024, when it jumped 21516.67%.
• Year by year, Long-Term Debt Issuances stood at -$1.7 million in 2020, then jumped by 164.71% to $1.1 million in 2021, then sank by 4072.73% to -$43.7 million in 2022, then surged by 96.11% to -$1.7 million in 2023, then surged by 7729.41% to $129.7 million in 2024.
• According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $129.7 million, $34.4 million, and $600000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.